1 Introduction Second-generation antipsychotics (SGAs) have emerged as the first-line treatment for schizophrenia due to their superior efficacy, reduced risk of extrapyramidal side effects and enhanced safety and tolerability (Lo et al. 2021). Among these agents, olanzapine is one of the most widely prescribed, owing to its lower propensity to induce tardive dyskinesia (De Simone et al. 2023).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile